Risks and benefits of systematic lymphadenectomy during interval debulking surgery for advanced high grade serous ovarian cancer-Reference-Cited by-同舟云学术

Risks and benefits of systematic lymphadenectomy during interval debulking surgery for advanced high grade serous ovarian cancer

Published:2022-01 Issue:1 Volume:48 Page:275-282
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Benoit Louise,Koual Meriem,Le Frère-Belda Marie-Aude,Zerbib Jonathan,Fournier Laure,Nguyen-Xuan Huyen-Thu,Delanoy Nicolas,Bentivegna Enrica,Bats Anne-Sophie,Azaïs Henri

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference33 articles.

1. Home,2012

2. Participants of 4th ovarian cancer consensus conference (OCCC), gynecologic cancer intergroup, 2010 gynecologic cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth ovarian cancer consensus conference;Stuart;Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc.,2011

3. European organization for research and treatment of cancer-gynaecological cancer group, NCIC clinical trials group, neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer;Vergote;N Engl J Med,2010

4. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis;Bristow;J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.,2002

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of systematic lymphadenectomy at the time of interval debulking surgery for patients with advanced-stage epithelial ovarian carcinoma who achieved complete gross resection;International Journal of Gynecologic Cancer;2024-05-16

2. Hyperthermic Intraperitoneal Chemotherapy (HIPEC): New Approaches and Controversies on the Treatment of Advanced Epithelial Ovarian Cancer—Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2023-11-09

3. Prognostic Value of Lymph Node Parameters in Elderly Patients With Stage III Serous Ovarian Cancer Based on Competing Risk Model;American Journal of Clinical Oncology;2023-05-05

4. Prediction for 2-year mortality of metastatic ovarian cancer patients based on surveillance, epidemiology, and end results database;Frontiers in Surgery;2022-09-15

5. Differences in Treatment Modalities and Prognosis of Elderly Patients with Ovarian Cancer: A Two-Center Propensity Score-Matched Study;Cancers;2022-07-27